Amorfix recruits ALS leader, Joseph Beckman, Ph.D. to join Scientific Advisory Board
12 Jun 2007 - Amorfix Life Sciences announced that Joseph Beckman, Ph.D., will join the Company's Scientific Advisory Board. Dr. Beckman is an expert in Amyotrophic Lateral Sclerosis (ALS) disease and the role of superoxide dismutase-1 (SOD1) in this disease. Anzeige


Dr. Beckman holds the Ava Helen Pauling Chair in the Linus Pauling Institute, is a Professor in the Department of Biochemistry and Biophysics and serves as the Director, Environmental Health Sciences Center at Oregon State University. He is an active contributor to a number of professional associations and has served as a regular reviewer for the National Institutes of Health and on a number of editorial boards of scientific journals.